Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 1× · first seen 09-sep-2026 · last seen 09-sep-2026

ASO Therapy Targeting LMNA/Progerin

Current understanding

To be populated as evidence accumulates.

Evidence log

Open questions

Related

Contributing findings

pubmed preclinical animal-model
AI-driven therapeutic antisense oligonucleotide for processing-deficient progeroid laminopathies.
01-jul-2026 novelty 4 per-area 4 strengthens

build build 880 · 2bcef25 · 2026-11-18